Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income	$ 12,089	$ 14,983
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,068	1,918
Net amortization of premiums on securities	882	1,443
Provision for credit losses	4,214	2,319
Share-based compensation	551	443
Deferred income tax benefit	417	554
Proceeds from sale of loans held for sale	3,416	11,383
Originations of loans held for sale	(3,436)	(10,816)
Income on company owned life insurance	(994)	(833)
Net (gain) loss on sale of loans held for sale	(112)	91
Net gain on other assets	(39)	0
Increase in other assets	8,319	1,083
(Decrease) increase in other liabilities	(20,813)	21,626
Net cash provided by operating activities	6,562	44,194
Cash flows from investing activities:
Purchases of available for sale securities	0	(50,669)
Purchases of held to maturity securities	(898)	(17,882)
Proceeds from principal payments, maturities and calls on available for sale securities	22,461	33,620
Proceeds from principal payments, maturities and calls on held to maturity securities	9,704	12,062
Net loan originations	(194,972)	(54,999)
Purchases of company owned life insurance	(12)	(10)
Purchases of premises and equipment	(848)	(1,216)
Net cash used in investing activities	(164,565)	(79,094)
Cash flows from financing activities:
Net increase in deposits	211,883	175,842
Net decrease in short-term borrowings	(89,000)	(30,000)
Proceeds from long-term borrowings	50,000	0
Purchases of common stock for treasury	(561)	(15,026)
Cash dividends paid to common and preferred shareholders	(4,811)	(4,624)
Net cash provided by financing activities	167,511	126,192
Net increase in cash and cash equivalents	9,508	91,292
Cash and cash equivalents, beginning of period	130,466	79,112
Cash and cash equivalents, end of period	$ 139,974	$ 170,404